Cauldron Appoints Biotech Veteran to Spearhead Hyper-Fermentation Solution for Alternative Proteins
Contract manufacturer organization Cauldron Ferm announces the appointment of Solugen and BASF industry veteran David Weiner as new chief technology officer. Drawing on his extensive experience in product development and scaling innovative biotech solutions, Weiner will oversee the company’s technology R&D pipeline as the Australian company embarks on its next phase of global expansion. Cauldron, founded in 2022 in Borenore, New South Wales, has developed a precision fermentation technology that promises to reach price parity — or even cheaper — with current goods such as dairy, egg, and silk proteins and widely used petrochemicals. The company recently closed a Series A funding round of over $6.25 million with investors including SOSV, In-Q-Tel, Main Sequence, and Horizons Ventures. “David brings a distinguished career leading R&D programs that …